Evidence map›Paper›PMID 29047214›Full record

ArticleJournal of cellular and molecular medicine2018

Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors.

Jie Li, Yan Zheng, Ming-Xian Li, Chu-Wei Yang, Yu-Fei Liu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Vimentin as a target for the treatment of COVID-19.BMJ open respiratory research · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jie LiDepartment of Geriatrics, the First Hospital of Jilin University, Changchun, China.
Yan ZhengDepartment of Geriatrics, the First Hospital of Jilin University, Changchun, China.
Ming-Xian LiDepartment of Respiratory, the First Hospital of Jilin University, Changchun, China.ORCID 0000-0002-2669-8836
Chu-Wei YangEmergency Department, the Second Hospital of Dalian Medical University, Dalian, China.
Yu-Fei LiuEmergency Department, the Second Hospital of Dalian Medical University, Dalian, China.
Jilin University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to investigate the role of Tanshinone IIA (Tan IIA) in lipopolysaccharide (LPS)-induced acute lung injury (ALI) in its regulation of TRPM7. Wistar male rats were randomly divided into the normal saline (NS), LPS, knockout (KO) + LPS, low-dose Tan IIA (Tan-L), middle-dose Tan IIA (Tan-M), high-dose Tan IIA (Tan-H) and KO + high-dose Tan IIA (KO + Tan-H) groups. The level of tumour necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, TRPM7 protein expression, current density-voltage curve and Ca

Indexed as

Down-RegulationAbietanesAcute Lung InjuryAnimalsCalciumInflammation MediatorsInterleukin-1betaInterleukin-6LipopolysaccharidesLungMacrophagesMaleOrgan SizeOxygenPartial PressureRats, WistarAbietanesCalciumInflammation MediatorsInterleukin-1betaInterleukin-6LipopolysaccharidesOxygentanshinoneTrpm7 protein, ratTRPM Cation ChannelsTumor Necrosis Factor-alphaacute lung injuryinterleukin 6lipopolysaccharideTanshinone IIAtransient receptor potential melastatin 7tumour necrosis factor alpha

Identifiers

PMID29047214
PMCPMC5742685
OpenAlexW2766194933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.